Virtual reality has expanded into many areas in recent years, moving well beyond its original gaming applications. At Cedars-Sinai, researchers are envisioning a new use for the technology: protecting people from high blood pressure.
When Mark Goodarzi, MD, PhD, first heard the phrase “Type 3c diabetes mellitus,” he was dubious. “Type 3c is not an official designation,” says the director of Endocrinology, Diabetes, and Metabolism at Cedars-Sinai. But today, Goodarzi leads a multisite research group studying Type 3c that is funded by a National Institutes of Health grant.
CASE STUDY 7: At the Kitchen Table Mindy Mamelak has been assembling a lot of meals lately — boxes filled with fig bars, string cheese, pasta with meat sauce, and peanut butter and honey sandwiches. It might sound like she’s Read On
Diabetic patients may one day rely on their own bone marrow for treatment. Researchers have reversed diabetes in animal models using stem cells derived from marrow. The method is not ready for human use just yet, but it suggests that Read On
A study has revealed a link between irritable bowel syndrome (IBS) and food poisoning and shows that military personnel are at a much higher risk for the disorder than the rest of the population. IBS is the most common gastrointestinal Read On
A much-awaited potential treatment developed at Cedars-Sinai shows promise of long-lasting relief for irritable bowel syndrome (IBS) sufferers. It uses the drug rifaximin, an oral antibiotic that is minimally absorbed, and therefore remains in the intestines to overcome abdominal pain Read On